Kura Oncology Inc (KURA)
20.63
+0.04
(+0.19%)
USD |
NASDAQ |
May 03, 16:00
20.63
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Total Assets (Quarterly): 553.91M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 553.91M |
December 31, 2023 | 448.94M |
September 30, 2023 | 473.77M |
June 30, 2023 | 494.74M |
March 31, 2023 | 425.98M |
December 31, 2022 | 456.31M |
September 30, 2022 | 447.99M |
June 30, 2022 | 471.42M |
March 31, 2022 | 498.58M |
December 31, 2021 | 534.05M |
September 30, 2021 | 561.14M |
June 30, 2021 | 584.89M |
March 31, 2021 | 620.26M |
December 31, 2020 | 647.21M |
September 30, 2020 | 339.57M |
June 30, 2020 | 353.00M |
March 31, 2020 | 226.46M |
December 31, 2019 | 241.97M |
Date | Value |
---|---|
September 30, 2019 | 254.60M |
June 30, 2019 | 265.68M |
March 31, 2019 | 169.62M |
December 31, 2018 | 182.38M |
September 30, 2018 | 191.50M |
June 30, 2018 | 129.63M |
March 31, 2018 | 141.46M |
December 31, 2017 | 95.85M |
September 30, 2017 | 103.12M |
June 30, 2017 | 55.85M |
March 31, 2017 | 61.92M |
December 31, 2016 | 69.82M |
September 30, 2016 | 76.30M |
June 30, 2016 | 81.74M |
March 31, 2016 | 80.38M |
December 31, 2015 | 87.26M |
September 30, 2015 | 42.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
226.46M
Minimum
Mar 2020
647.21M
Maximum
Dec 2020
445.02M
Average
463.87M
Median
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 19.38M |
Perspective Therapeutics Inc | 97.89M |
Protalix BioTherapeutics Inc | 84.43M |
Electromed Inc | 46.96M |
Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 48.82M |
Shareholders Equity (Quarterly) | 505.08M |